0001375151-18-000055.txt : 20180705 0001375151-18-000055.hdr.sgml : 20180705 20180705160603 ACCESSION NUMBER: 0001375151-18-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180705 DATE AS OF CHANGE: 20180705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sagrolikar Ashish M CENTRAL INDEX KEY: 0001745512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 18940626 MAIL ADDRESS: STREET 1: C/O ZOGENIX, INC. STREET 2: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_153082114709959.xml FORM 4 X0306 4 2018-07-02 0 0001375151 ZOGENIX, INC. ZGNX 0001745512 Sagrolikar Ashish M C/O ZOGENIX, INC. 5858 HORTON STREET, SUITE 455 EMERYVILLE CA 94608 0 1 0 0 EVP & CHIEF COMMERCIAL OFFICER Restricted Stock Units 2018-07-02 4 A 0 15000 0 A 15000 D Stock Option (Right to Buy) 43.7 2018-07-02 4 A 0 100000 0 A 2028-07-01 Common Stock 100000.0 100000 D Issued pursuant to Zogenix's Employment Inducement Equity Incentive Award Plan. Each restricted stock unit (RSU) represents a contingent right to receive one share of Zogenix common stock. The RSUs shall vest over a four-year period at the rate of 25% of the RSUs on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with Zogenix on each vesting date. The options shall vest over a four-year period, with 25% of the options vesting on the first anniversary of the date of grant and the remainder vesting in equal monthly installments over the three years thereafter, subject to the Reporting Person's continuous service to Zogenix on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Ashish Sagrolikar 2018-07-05